Higher buprenorphine dose may keep more people in opioid treatment
NCT ID NCT06316830
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a higher daily dose of buprenorphine (24 mg) to the standard dose (16 mg) to see if it helps people with opioid use disorder stay in treatment longer. About 250 adults who have used fentanyl will be randomly assigned to one of the two doses. The goal is to improve retention, reduce cravings, and lower the risk of overdose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Brown University
RECRUITINGProvidence, Rhode Island, 02912, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••